MMA.INC (Mixed Martial Arts Group Limited) is revolutionizing the combat sports industry by driving participation and engagement across fans, athletes, coaches, and gym owners. The company operates ...

Optical coherence tomography markers—like the ellipsoid zone—are reshaping clinical trials in intermediate age-related ...

Ocular Therapeutix showcases innovative retinal disease treatments at the Clinical Trials Summit 2025 in Las Vegas, featuring ...

Although GLP-1 drugs make headlines for vision risks, other weight-loss medications carry their own eye-related side effects.

Struggling with eye strain or blurry vision? Here’s my honest iGenics reviews after 45 days — what worked, what didn’t, and ...

Although the number of people receiving national health checkups or comprehensive checkups on a regular basis is increasing, ...

Partner: Aura Biosciences Title: Bel-sar - a New Treatment Paradigm in Choroidal Melanoma: Update on the Global Phase 3 CoMpass Trial Presented by: Jennifer Lim, MD, Professor of Ophthalmology, ...

The US FDA has approved Ocugen’s IND amendment to commence a Phase II/III pivotal confirmatory study of OCU410ST.

Please ensure you refill your cup of coffee as we inform you about how to claim up to $5,300 before the deadline for this ...

The widefield imaging systems market has been gaining significant traction in recent years, driven by the increasing need for ...

Don’t smoke: Smokers are more likely to develop diseases of the eyes that lead to vision loss, including AMD, glaucoma, and ...